Month: July 2025

Budget Reconciliation’s Effects Could Shape Efforts to Reform 340B, Policy Experts Say at 340B Coalition Conference

July 24, 2025 Shannon Young, Associate Editor/Senior Writer Views

Tom O’Donnell (left) and Michael McCaughan (right) speak at the 340B Coalition Summer Conference in National Harbor, Md.

The debate over federal drug pricing reform could garner newfound attention on Capitol Hill now that Congress has wrapped up [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Separating AI Hype from Real Value in 340B Program Management

July 24, 2025 Sponsored Content Views

Not all “AI-powered” tools are created equal. Spot what’s useful, what’s fluff, and what to ask vendors next.

Analysis: How Medicaid Cuts in ‘Big Beautiful Bill’ Could Push Certain Hospitals Out of 340B and the Importance of Planning Ahead

July 24, 2025 William Newton, Associate Editor/Senior Writer Views

Experts warn that recently enacted Medicaid cuts could jeopardize some hospitals' 340B eligibility.

Although President Donald Trump’s nearly 900-page “big beautiful bill” never mentions the 340B program, experts warn that the new law’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: Updates in Colorado, Nebraska

July 24, 2025 William Newton, Associate Editor/Senior Writer Views

Key briefs were filed in Colorado and Nebraska in ongoing state 340B contract pharmacy litigation.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Matsui, Welch Reintroduce 340B PATIENTS Act in Congress During 340B Coalition Summer Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Rep. Doris Matsui (D-Calif.) and U.S. Sen. Peter Welch (D-Vt.) reintroduced the 340B PATIENTS Act during the 340B Coalition annual summer conference.

The two congressional Democrats behind the 340B PATIENTS Act—a 2024 federal bill that would’ve codified providers’ ability to use 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

OPA Director Touches on 340B Rebate Litigation and Other Key Matters at 340B Coalition Conference

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Office of Pharmacy Affairs (OPA) Director Chantelle Britton addresses 340B stakeholders during remarks to open the 340B Coalition’s annual summer conference in National Harbor, Md. on Monday.

A key federal regulator highlighted the Health Resources and Services Administration’s (HRSA) legal fight against proposed drugmaker 340B rebate models [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B PATIENTS Act Reintroduction Expected Soon, Hospital Trade Group Challenges Drug Industry Criticisms

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B Health President and CEO Maureen Testoni speaks at the 340B Coalition's Summer Conference in National Harbor, Md. on Monday.

The leader of a major 340B hospital trade group heralded the forthcoming reintroduction of a federal bill that would codify [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Safeguarding Your 340B Program

July 22, 2025 Sponsored Content Views

Strategies to Fortify Your 340B Program Amid
Federal Policy Shifts

Introduction: Navigating Political Headwinds

As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement spending,

…

Federal Court Consolidates Drugmaker 340B Rebate Appeals, Denies Hospital Group’s Cross-Appeal Request

July 22, 2025 William Newton, Associate Editor/Senior Writer Views

A federal appeals court in Washington, D.C. consolidated multiple drugmaker appeals in ongoing 340B rebate litigation.

A Washington, D.C. federal appellate court on Friday consolidated multiple drug industry appeals challenging the government’s authority to preapprove 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GSK Exempts New States from 340B Contract Pharmacy Restrictions, Teva Issues New Update on Restricted Drugs

July 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

GSK and Teva recently announced new changes to their 340B contract pharmacy restrictions.

Two major drugmakers announced new changes to their 340B contract pharmacy restrictions in notices posted to 340B ESP’s website late [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Introduction: Navigating Political Headwinds

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live